Brief: Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) To Newly Appointed President And Chief Executive Officer

Dyne Therapeutics

27/03/2024 20:10

March 27 (Reuters) - Dyne Therapeutics Inc  DYN.O :
    * DYNE THERAPEUTICS REPORTS INDUCEMENT GRANT UNDER NASDAQ
LISTING
RULE 5635(C)(4) TO NEWLY APPOINTED PRESIDENT AND CHIEF EXECUTIVE
OFFICER

Source text for Eikon:  ID:nGNX5sT30p 
Further company coverage:  DYN.O 

 ((Reuters.Briefs@thomsonreuters.com;))